Merck to invest over €440m to expand manufacturing capacity in Ireland

By NS Healthcare Staff Writer

24 May 22

The investment will enhance the membrane manufacturing capacities, enables the construction of a new filtration manufacturing facility, and…

PharmaceuticalsManufacturing

AstraZeneca gets EMA approval for Vaxzevria booster dose in adults

By NS Healthcare Staff Writer

24 May 22

The EC approval follows positive CHMP recommendation in patients previously vaccinated with Vaxzevria or an EU-approved mRNA Covid-19…

PharmaceuticalsRegulation

Sanofi, Regeneron’s Dupixent approved in US to treat eosinophilic esophagitis in children

By NS Healthcare Staff Writer

23 May 22

The FDA approval is based on data from a Phase 3 trial, conducted in two parts, Part A…

PharmaceuticalsRegulation

VerImmune, Fosun Pharma collaborate on ViP platform-based therapies in China

By NS Healthcare Staff Writer

23 May 22

Fosun Pharma will obtain an exclusive license to VerImmune’s lead AIR-ViP product candidate, VERI-101, in Mainland China, Hong…

PharmaceuticalsPartnerships and Licensing Agreements

Biocon Biologics, Viatris roll out Avastin biosimilar Abevmy in Canada

By NS Healthcare Staff Writer

20 May 22

Abevmy marks the third oncology biosimilar to be launched by the partnership in Canada, following Ogivri (bTrastuzumab) in…

PharmaceuticalsRegulation

Boehringer Ingelheim’s Jardiance approved in India to treat heart failure

By NS Healthcare Staff Writer

20 May 22

The CDSCO approval is based on results from the Phased 3 EMPEROR-Preserved trial which evaluated Jardiance 10mg, compared…

PharmaceuticalsRegulation

Moderna, IAVI to begin first clinical trial of mRNA HIV vaccine in Africa

By NS Healthcare Staff Writer

19 May 22

The Phase 1 clinical trial in Rwanda and South Africa aims to evaluate mRNA HIV vaccine antigen for…

PharmaceuticalsClinical trials

FDA approves booster dose of Pfizer-BioNTech Covid-19 vaccine in kids aged five to 11 years

By NS Healthcare Staff Writer

18 May 22

The expanded EUA is based on data, showing booster dose of Pfizer-BioNTech Covid-19 Vaccine induced superior immune response…

PharmaceuticalsRegulation

AstraZeneca teams up with RQ Bio for mAbs against Covid-19

By NS Healthcare Staff Writer

18 May 22

AstraZeneca will obtain an exclusive global licence to develop, manufacture and commercialise pre-clinical Covid-19 antibodies engineered by RQ…

PharmaceuticalsPartnerships and Licensing Agreements

Emergent to acquire rights to Chimerix’s smallpox treatment Tembexa

By NS Healthcare Staff Writer

17 May 22

Chimerix is expected to receive $225m as a one-time upfront payment and is eligible to receive a total…

PharmaceuticalsPartnerships and Licensing Agreements